Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME
Status:
Recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to test the hypothesis that following the use of intravitreal
dexamethasone implant for the treatment of DME, there will be an observable increase in the
capillary density plexus as denoted by the quantitative assessment of the superficial
capillary plexus on OCTA, as well as a decrease in size of the foveal avascular zone (FAZ).